TP53 and cancer: While many other tumor suppressor genes are predominantly inactivated through the deletion or truncating mutations in cancer, the majority of p53 mutations in human cancers are missense mutations that lead to the expression of full-length mutant p53 proteins with the substitution of a single amino acid.